{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:02:46Z","timestamp":1774069366056,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Scripps startup funds"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.05.011","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T06:24:00Z","timestamp":1433571840000},"page":"66-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Supriya","family":"Swarnkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Shahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damon T.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.05.011_bb0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.05.011_bb0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.05.011_bb0015","doi-asserted-by":"crossref","first-page":"e53606","DOI":"10.1371\/journal.pone.0053606","article-title":"Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease","volume":"8","author":"Baiamonte","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.05.011_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2012.05.073","article-title":"Striatum specific protein, Rhes regulates AKT pathway","volume":"521","author":"Bang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.05.011_bb0025","doi-asserted-by":"crossref","first-page":"13372","DOI":"10.1073\/pnas.230362997","article-title":"Role of the calcium-binding protein parvalbumin in short-term synaptic plasticity","volume":"97","author":"Caillard","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.011_bb0030","article-title":"Effects of the pimelic diphenylamide histone deacetylase inhibitor HDACi 4b on the R6\/2 and N171-82Q mouse models of Huntington's disease","volume":"5","author":"Chen","year":"2013","journal-title":"PLoS Curr."},{"key":"10.1016\/j.nbd.2015.05.011_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2013.00114","article-title":"Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0040","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2011.02.022","article-title":"Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model","volume":"56","author":"Cheng","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2015.05.011_bb0045","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2015.05.011_bb0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1749-6632.1969.tb12983.x","article-title":"Open-field behavior in the rat: what does it mean?","volume":"159","author":"Denenberg","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0055","doi-asserted-by":"crossref","first-page":"17822","DOI":"10.1073\/pnas.0509062102","article-title":"Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann\u2013Pick type A disease","volume":"102","author":"Dodge","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.011_bb0060","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.011_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.05.011_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2015.05.011_bb0075","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.mcn.2007.10.007","article-title":"The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons","volume":"37","author":"Errico","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0080","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9","article-title":"Rhes: a striatal-specific Ras homolog related to Dexras1","volume":"57","author":"Falk","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2015.05.011_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.05.011_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12035-012-8315-4","article-title":"Mouse models of polyglutamine diseases: review and data table. Part I","volume":"46","author":"Figiel","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.parkreldis.2008.05.010","article-title":"Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number","volume":"15","author":"Gomez-Anson","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2015.05.011_bb0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.05.011_bb0115","series-title":"The Neuropathology of Huntington's Disease","author":"Gutekunst","year":"2002"},{"key":"10.1016\/j.nbd.2015.05.011_bb0120","first-page":"1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2015.05.011_bb0125","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10571-012-9830-6","article-title":"Rhes: a GTP-binding protein integral to striatal physiology and pathology","volume":"32","author":"Harrison","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2008.09.066","article-title":"Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes)","volume":"1245","author":"Harrison","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2015.05.011_bb0135","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","article-title":"Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease","volume":"27","author":"Heng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jnnp.2009.190702","article-title":"The progression of regional atrophy in premanifest and early Huntington's disease: a longitudinal voxel-based morphometry study","volume":"81","author":"Hobbs","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2015.05.011_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2990.1995.tb01024.x","article-title":"The cortical neuritic pathology of Huntington's disease","volume":"21","author":"Jackson","year":"1995","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0150","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems","volume":"21","author":"Jia","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0155","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddt098","article-title":"Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease","volume":"22","author":"Jiang","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2014.00103","article-title":"Risk-taking and pathological gambling behavior in Huntington's disease","volume":"8","author":"Kalkhoven","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0165","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0170","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/ncb1478","article-title":"Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state","volume":"8","author":"Kitamura","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0175","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.nbd.2015.05.011_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2010.12.012","article-title":"Mice lacking rhes show altered morphine analgesia, tolerance, and dependence","volume":"489","author":"Lee","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2015.05.011_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JHD-140094","article-title":"Rhes suppression enhances disease phenotypes in Huntington's disease mice","volume":"3","author":"Lee","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.nbd.2015.05.011_bb0190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tig.2004.01.008","article-title":"Huntingtin\u2013protein interactions and the pathogenesis of Huntington's disease","volume":"20","author":"Li","year":"2004","journal-title":"Trends Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb9000","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","article-title":"Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes","volume":"85","author":"Lee","year":"2015","journal-title":"Neuron."},{"key":"10.1016\/j.nbd.2015.05.011_bb0195","first-page":"1357","article-title":"Application and development of purification in cancer genomics research","volume":"23","author":"Liu","year":"2004","journal-title":"Ai Zheng"},{"key":"10.1016\/j.nbd.2015.05.011_bb0200","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.12-219220","article-title":"A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration","volume":"27","author":"Lu","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2015.05.011_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2010.106","article-title":"Defining the transcriptome and proteome in three functionally different human cell lines","volume":"6","author":"Lundberg","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0210","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2008.01.014","article-title":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","volume":"30","author":"Masuda","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.05.011_bb0225","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1523\/JNEUROSCI.3730-12.2013","article-title":"Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease","volume":"33","author":"Mealer","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0220","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.M113.536912","article-title":"Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy","volume":"14","author":"Mealer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0230","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.nbd.2010.07.014","article-title":"Cerebral cortex structure in prodromal Huntington disease","volume":"40","author":"Nopoulos","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2015.05.011_bb0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.05.011_bb0235","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","article-title":"SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation","volume":"4","author":"O'Rourke","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2015.05.011_bb0245","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1074\/jbc.M710606200","article-title":"Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice","volume":"283","author":"Orr","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/hmg\/ddi071","article-title":"A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure","volume":"14","author":"Poirier","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0255","doi-asserted-by":"crossref","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","article-title":"Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease","volume":"7","author":"Pryor","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.nbd.2015.05.011_bb0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/NDT.S25888","article-title":"Exploration of sex differences in Rhes effects in dopamine mediated behaviors","volume":"7","author":"Quintero","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2015.05.011_bb0265","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/WNR.0b013e3283118434","article-title":"The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice","volume":"19","author":"Quintero","year":"2008","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2015.05.011_bb0270","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1074\/jbc.M804813200","article-title":"Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells","volume":"284","author":"Ratovitski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0275","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/mds.25984","article-title":"Cerebellar abnormalities in Huntington's disease: a role in motor and psychiatric impairment?","volume":"29","author":"Rees","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2015.05.011_bb0280","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.05.011_bb0285","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","article-title":"Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease","volume":"19","author":"Rose","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0290","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cell.2004.06.022","article-title":"Huntington's disease: new paths to pathogenesis","volume":"118","author":"Ross","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.05.011_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1590\/S0004-282X2006000100002","article-title":"Clinical presentation of juvenile Huntington disease","volume":"64","author":"Ruocco","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.nbd.2015.05.011_bb0300","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1590\/S0100-879X2006000800016","article-title":"Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat","volume":"39","author":"Ruocco","year":"2006","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.nbd.2015.05.011_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.05.011_bb0310","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.celrep.2013.08.001","article-title":"Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease","volume":"4","author":"Sbodio","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2015.05.011_bb0315","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2015.05.011_bb0320","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature10098","article-title":"Global quantification of mammalian gene expression control","volume":"473","author":"Schwanhausser","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.05.011_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0022231","article-title":"Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation","volume":"6","author":"Seredenina","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.05.011_bb0330","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1074\/jbc.M113.532713","article-title":"Rheb GTPase regulates beta-secretase levels and amyloid beta generation","volume":"289","author":"Shahani","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0335","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1128\/MCB.24.13.5788-5796.2004","article-title":"Rhes is involved in striatal function","volume":"24","author":"Spano","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0340","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2015.05.011_bb0345","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington's disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.05.011_bb0365","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.neuropharm.2010.10.025","article-title":"Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum)","volume":"60","author":"Subramaniam","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.05.011_bb0360","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.1172871","article-title":"Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity","volume":"324","author":"Subramaniam","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.05.011_bb0350","doi-asserted-by":"crossref","first-page":"20428","DOI":"10.1074\/jbc.C110.127191","article-title":"Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9","volume":"285","author":"Subramaniam","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.011_bb0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nn.2994","article-title":"Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia","volume":"15","author":"Subramaniam","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0375","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group.","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2015.05.011_bb0380","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1523\/JNEUROSCI.14-08-04915.1994","article-title":"Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction","volume":"14","author":"Usui","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.011_bb0385","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.onc.1207161","article-title":"The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors","volume":"23","author":"Vargiu","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2015.05.011_bb0390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.47.1.249","article-title":"Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1","volume":"47","author":"Vig","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.05.011_bb0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.50.1.106","article-title":"Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice","volume":"50","author":"Vig","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.05.011_bb0400","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12311-011-0323-9","article-title":"Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model","volume":"11","author":"Vig","year":"2012","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2015.05.011_bb0405","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/msb.2010.59","article-title":"Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line","volume":"6","author":"Vogel","year":"2010","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0410","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.05.011_bb0415","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","article-title":"Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin","volume":"32","author":"Waldron-Roby","year":"2012","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T23:46:10Z","timestamp":1599090370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":84,"alternative-id":["S0969996115001850"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.011","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725538487.793507607","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}